Tradewinds LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,146
Closed -$255K 269
2025
Q1
$255K Sell
3,146
-2,587
-45% -$231K 0.07% 177
2024
Q4
$509K Buy
+5,733
New +$555K 0.14% 117

Other funds holding XBI

Tradewinds LLC's XBI Position: Q2 2025 in Review

Tradewinds LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 3,146 shares — an estimated $255K sold.

Tradewinds LLC first reported a position in XBI in Q4 2024 and held it in 2 quarters. The position peaked at $509K in Q4 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Tradewinds LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Tradewinds LLC sold 3,146 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $255K.
  • Tradewinds LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and held it in 2 quarters.
  • Tradewinds LLC's State Street SPDR S&P Biotech ETF position peaked at $509K in Q4 2024.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Tradewinds LLC's 13F filing for Q2 2025, filed 6 Aug 2025.